The function of the Responsible Person (RP) in the context of pharmaceutical wholesale distribution, as outlined by Good Distribution Practice (GDP) guidelines, is to ensure the integrity, safety, and quality of pharmaceutical products throughout the entire distribution process. The RP plays a critical role in maintaining compliance with regulatory requirements and safeguarding public health. Here are the primary functions and responsibilities of the RP:

  1. Overall Oversight: The RP is responsible for overall oversight of the pharmaceutical distribution activities carried out by the organisation holding the Wholesale Distribution Authorisation (WDA).
  2. Compliance with Regulations: Ensure that all pharmaceutical distribution activities comply with the applicable regulatory requirements, including national and international standards such as GDP and relevant laws and guidelines.
  3. License Holder Representation: Act as the primary point of contact between the organisation and regulatory authorities. The RP is typically named on the WDA and represents the organisation in interactions with regulatory agencies.
  4. Quality Assurance: Implement and maintain a comprehensive quality management system (QMS) that covers all aspects of pharmaceutical distribution. This includes establishing and enforcing quality standards and procedures.
  5. Supplier Qualification: Establish and maintain procedures for the qualification and monitoring of suppliers and contractors involved in the distribution process. This includes conducting supplier audits and assessing their compliance with quality and regulatory requirements.
  6. Documentation: Ensure that accurate and complete records are maintained for all pharmaceutical transactions. This includes records of product receipt, storage conditions, transportation, and any deviations from standard procedures.
  7. Storage and Handling: Ensure that pharmaceutical products are stored and handled in compliance with GDP, including temperature control and security measures.
  8. Security: Implement security measures to prevent theft, diversion, and unauthorised access to pharmaceutical products. This may include security systems, access controls, and monitoring of storage facilities.
  9. Product Recall and Complaint Handling: Develop and maintain procedures for handling product recalls and managing complaints related to pharmaceutical products. The RP should be prepared to take immediate action in case of quality or safety concerns.
  10. Auditing and Self-Inspection: Conduct regular audits and self-inspections of the distribution processes and facilities to identify and rectify any non-compliance issues. Implement corrective and preventive actions as needed.
  11. Communication with Regulatory Authorities: Maintain open and transparent communication with regulatory authorities. The RP should be prepared to provide information and documentation as requested during inspections and investigations.
  12. Training and Competency: Ensure that all personnel involved in distribution activities receive appropriate training and possess the necessary competencies to perform their roles effectively and in compliance with GDP.
  13. Change Control: Implement a change control process to assess and manage changes in the distribution process, including changes in suppliers, distribution routes, or storage facilities.
  14. Post-Market Surveillance: Monitor the safety and quality of pharmaceutical products in the market and take appropriate actions in case of adverse events or quality issues.
  15. Continuous Improvement: Continuously assess and improve the pharmaceutical distribution processes to enhance efficiency, reliability, and compliance with regulations.

The RP plays a pivotal role in ensuring the integrity of the pharmaceutical supply chain and safeguarding patient safety by making certain that pharmaceutical products are distributed in a manner that meets high-quality standards and complies with all applicable regulations. The responsibilities of the RP are critical to maintaining public trust in the pharmaceutical industry.


For any questions get in touch with us at